Optovite B12 (Cyanocobalamin)

Cyanocobalamin, the active ingredient in Optovite B12, is a Vitamin B12 presented as a supplement for oral, intramuscular, and intravenous use. It is used to treat vitamin B12 deficiency and related anemias in patients of all ages.\n\nGNH India supplies Optovite B12 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Optovite B12 provides cyanocobalamin to address disorders of cobalamin metabolism and related hematologic conditions.\n\nVitamin B12 deficiency: restores normal cobalamin levels and supports red blood cell formation.\nPernicious anemia: compensates for intrinsic factor deficiency and improves hematologic parameters.\nCobalamin deficiency anemia: corrects anemia caused by inadequate vitamin B12 availability.

Adverse reactions to cyanocobalamin may vary with the route of administration.\n\nCommon Side Effects:\n- Injection site pain or irritation\n- Mild gastrointestinal upset such as nausea or diarrhea\n- Transient headache or dizziness\n\nSerious or Rare Side Effects:\n- Anaphylactic reaction or severe hypersensitivity\n- Thrombophlebitis at injection site\n- Serum sickness‑like symptoms or severe skin rash

Cyanocobalamin should be used with consideration of patient‑specific factors and proper handling.\n\nAssess B12 status before initiating therapy: confirm deficiency through laboratory testing.\nMonitor hematologic parameters during treatment: check hemoglobin and MCV regularly.\nUse caution in patients with renal impairment: adjust monitoring as needed.\nAvoid in individuals with known hypersensitivity to cyanocobalamin or formulation excipients.\nStore at below 25°C: keep in the original packaging, protect from moisture and light.

Cyanocobalamin may interact with other medications that affect its absorption or metabolism.\n\nMajor Interactions (Avoid):\n- Proton pump inhibitors: may impair gastrointestinal absorption of vitamin B12.\n- Chloramphenicol: can interfere with cobalamin metabolism.\n\nModerate Interactions (Monitor Closely):\n- Metformin: may reduce serum B12 levels over long‑term use.\n- H2‑blockers (e.g., cimetidine): can decrease B12 absorption.\n- Anticonvulsants such as phenytoin: may increase B12 requirement.